$7.8m Cash Balance Financial – Cash of $7.8 million at 30 June 2023 to fund operations and pipeline development – Net loss of $9.0 million for the year ended 30 June 2023 (increased operating loss in the current period driven by legal fees and subsequent legal settlement costs as outlined in the Operating Results commentary below) – Research and Development Tax Refund of $0.95m recognised for the 2023 financial year Corporate – Settled legal proceeding related to BARD1 performance shares – EXO-NET R&D and manufacturing centralised to upgraded Melbourne laboratory, streamlining R&D activities and enabling expanded production capacity – Mr Mark Edwards appointed as CFO & Company Secretary, bringing substantial financial, governance and corporate expertise – Professor Greg Rice, Chief Scientific Officer, awarded the prestigious Joan Hunt IFPA Senior Award in Placentology for 2023 – Vale Professor Emeritus Allan Cripps AO, who made a valuable contribution to INOVIQ during his time as NonExecutive Director from January 2020 to December 2022 7 Annual Report 2023
RkJQdWJsaXNoZXIy MjE2NDg3